Interfractional body surface monitoring using daily cone-beam computed tomography imaging for pediatric adaptive proton therapy.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
BACKGROUND AND PURPOSE: A novel method was developed to detect body surface changes on daily cone-beam computed tomography (CBCT) and estimate the impact on proton plan quality for pediatric patients. MATERIALS AND METHODS: Simulation CT, daily CBCT, and repeat CT images were collected for 21 pediatric non-central nervous system (CNS) patients. Changes in the body surface in the proton beam path (ΔSurfaceCBCT) were calculated for each spot by comparing simulation CT with daily CBCT. Subsequently, changes in water equivalent path length (WEPL) (ΔWEPLSynthetic CT) were calculated for each spot by comparing the simulation CT with the synthetic CT converted from daily CBCT. The ground truth surface (ΔSurfaceRepeat CT) and WEPL changes (ΔWEPLRepeat CT) were calculated by comparing the simulation CT with the repeat CT taken on the same day as the CBCT. RESULTS: The root-mean-square (RMS) error between the ΔSurfaceCBCT and ΔSurfaceRepeat CT was 1.3 mm, while the RMS error between ΔWEPLSynthetic CT and ΔWEPLRepeat CT was 1.6 mm. A strong linear correlation was determined between ΔSurfaceCBCT and ΔWEPLSynthetic CT (R2 = 0.97). The non-linear regression analysis of the dose volume parameters indicated that a 5 % decrease in clinical target volume (CTV) Dmin and D99% was caused by 3.9 mm and 6.3 mm of ΔSurfaceCBCT, and 4.0 mm and 6.6 mm of ΔWEPLSynthetic CT, respectively. CONCLUSIONS: The findings revealed that a 5 mm change in body surface can lead to a significant degradation of plan quality, reducing CTV Dmin by 11.7 % and underscoring the need for adapting treatment plan.